Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-07

Clinical Trial Update: Swiss Multi-centre, Randomized, Placebo Controlled Trial of Pregabalin for Prevention of Persistent Pain in High Risk Patients Undergoing Breast Cancer Surgery [Phase 3]

View source ↗

Summary

A multicenter Phase 3 randomized, placebo-controlled trial evaluating pregabalin to prevent persistent postoperative pain in high-risk breast cancer surgery pat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

Sponsor: Benno Rehberg-Klug | Conditions: Persistent Postoperative Pain | Phase 3 | Status: TERMINATED